Navigation Links
Arizona Heart Innovative Technologies Licenses New Endovascular Device
Date:11/12/2008

PHOENIX, Nov. 12 /PRNewswire/ -- Arizona Heart Innovative Technologies, LLC (AHIT) announced the license of a new medical device for endovascular use to a publicly traded medical device company. "This is the second AHIT-developed product that we have licensed in the past ten months. We continue to demonstrate our ability to bridge the gap between good ideas from the medical community to commercially viable products for medical device companies. This confirms the viability of our business model to serve as a cost-effective supplementary research and development resource for companies," says AHIT President and CEO, Bill Colone. "We have additional products that have completed the development process and we are continuing to discuss options with many device companies."

AHIT licensed the endovascular product in July of 2007 from Hani Shennib, MD, a cardiovascular surgeon formerly at the Arizona Heart Hospital. The product was prototyped, tested and marketed to multiple medical companies immediately following positive clinical test results. The product should reach both the U.S. and international markets by the first quarter of 2009.

About Arizona Heart Innovative Technologies, LLC

Bill Colone, who co-founded AHIT in August 2006, has over 26 years of experience in developing and marketing medical devices. He served as President of Endomed, Inc. for over ten years, until its sale to LeMaitre Vascular (LMAT) in February 2005. Bill holds eleven US patents for medical devices with other applications pending.

AHIT provides a vehicle for evaluating and commercializing ideas from the medical community. This process includes product due diligence, market research, securing intellectual property rights, prototyping, and matching the product to the best medical device company through a sales process. The company's Scientific Advisory Board (SAB) consists of cardiovascular surgeons and endovascular specialists with over 80 years of experience treating vascular disease. The SAB is chaired by Edward B. Diethrich, MD, the Medical Director and Founder of the Arizona Heart Institute and Arizona Heart Hospital. AHIT is supported by a Governing Board which includes many prominent business professionals with expertise in patent law, financial services, corporate management, and medical device marketing.

If you would like to discuss your idea or concept, please contact us:

Arizona Heart Innovative Technologies, LLC

10429 South 51st Street, Suite 220, Phoenix, AZ 85044

Tel: 602.200.0898 Fax: 602.200.0899

Email: bcolone@ahitechnologies.com

Web: http://www.ahitechnologies.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Arizona Heart Innovative Technologies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
3. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
4. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
5. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
6. First Annual Arizona Biotech Day Announced for October 23rd 2008
7. Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval
8. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
9. ATS Medical Expands Open Pivot Heart Valve Offerings
10. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
11. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions ... over 5.5 million people each year. Especially those living in larger cities are affected ... based in one of the most pollution-affected countries globally - decided to take action. ...
Breaking Biology Technology:
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert ... a media edge server, the M820, which features the company,s hybrid ... software provided by Tera Probe, Inc., will be showcased during the ... the NAB show at the Las Vegas ... ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
Breaking Biology News(10 mins):